168 related articles for article (PubMed ID: 28117438)
1. A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability.
Vasaturo M; Fiengo L; De Tommasi N; Sabatino L; Ziccardi P; Colantuoni V; Bruno M; Cerchia C; Novellino E; Lupo A; Lavecchia A; Piaz FD
Sci Rep; 2017 Jan; 7():41273. PubMed ID: 28117438
[TBL] [Abstract][Full Text] [Related]
2. The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands.
Zurlo D; Ziccardi P; Votino C; Colangelo T; Cerchia C; Dal Piaz F; Dallavalle S; Moricca S; Novellino E; Lavecchia A; Colantuoni V; Lupo A
Biochem Pharmacol; 2016 May; 108():22-35. PubMed ID: 26995279
[TBL] [Abstract][Full Text] [Related]
3. Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
Puhl AC; Bernardes A; Silveira RL; Yuan J; Campos JL; Saidemberg DM; Palma MS; Cvoro A; Ayers SD; Webb P; Reinach PS; Skaf MS; Polikarpov I
Mol Pharmacol; 2012 Jun; 81(6):788-99. PubMed ID: 22391103
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
[TBL] [Abstract][Full Text] [Related]
5. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.
Ye F; Zhang ZS; Luo HB; Shen JH; Chen KX; Shen X; Jiang HL
Chembiochem; 2006 Jan; 7(1):74-82. PubMed ID: 16317783
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.
Jang JY; Koh M; Bae H; An DR; Im HN; Kim HS; Yoon JY; Yoon HJ; Han BW; Park SB; Suh SW
Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):674-681. PubMed ID: 28342850
[TBL] [Abstract][Full Text] [Related]
8. Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists.
Sabatino L; Ziccardi P; Cerchia C; Muccillo L; Piemontese L; Loiodice F; Colantuoni V; Lupo A; Lavecchia A
Sci Rep; 2019 Apr; 9(1):5434. PubMed ID: 30931956
[TBL] [Abstract][Full Text] [Related]
9. Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells.
Colin C; Meyer M; Cerella C; Kleinclauss A; Monard G; Boisbrun M; Diederich M; Flament S; Grillier-Vuissoz I; Kuntz S
Int J Oncol; 2018 Jun; 52(6):1991-2000. PubMed ID: 29620161
[TBL] [Abstract][Full Text] [Related]
10. Importance of the Proximity and Orientation of Ligand-Linkage to the Design of Cinnamate-GW9662 Hybrid Compounds as Covalent PPARγ Agonists.
Utsugi Y; Kobuchi H; Kawamura Y; Atito ASA; Nagao M; Isoda H; Miyamae Y
Molecules; 2019 May; 24(10):. PubMed ID: 31137814
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists.
Knape T; Flesch D; Kuchler L; Sha LK; Giegerich AK; Labocha S; Ferreirós N; Schmid T; Wurglics M; Schubert-Zsilavecz M; Proschak E; Brüne B; Parnham MJ; von Knethen A
Eur J Pharmacol; 2015 May; 755():16-26. PubMed ID: 25746464
[TBL] [Abstract][Full Text] [Related]
12. Identification of a New Type of Covalent PPARγ Agonist using a Ligand-Linking Strategy.
Ohtera A; Miyamae Y; Yoshida K; Maejima K; Akita T; Kakizuka A; Irie K; Masuda S; Kambe T; Nagao M
ACS Chem Biol; 2015 Dec; 10(12):2794-804. PubMed ID: 26414848
[TBL] [Abstract][Full Text] [Related]
13. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
14. 2-Formyl-komarovicine promotes adiponectin production in human mesenchymal stem cells through PPARγ partial agonism.
Ahn S; Lee M; An S; Hyun S; Hwang J; Lee J; Noh M
Bioorg Med Chem; 2018 Mar; 26(5):1069-1075. PubMed ID: 29398443
[TBL] [Abstract][Full Text] [Related]
15. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
Burgermeister E; Schnoebelen A; Flament A; Benz J; Stihle M; Gsell B; Rufer A; Ruf A; Kuhn B; Märki HP; Mizrahi J; Sebokova E; Niesor E; Meyer M
Mol Endocrinol; 2006 Apr; 20(4):809-30. PubMed ID: 16373399
[TBL] [Abstract][Full Text] [Related]
16. Agonism activities of lyso-phosphatidylcholines (LPC) Ligands binding to peroxisome proliferator-activated receptor gamma (PPARγ).
Wang J; Wang B; Zhang Y
J Biomol Struct Dyn; 2020 Feb; 38(2):398-409. PubMed ID: 31025599
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of peroxisome proliferator-activated receptor gamma (PPARγ) transactivation by hesperetin glucuronides is distinct from that by a thiazolidine-2,4-dione agent.
Gamo K; Shiraki T; Matsuura N; Miyachi H
Chem Pharm Bull (Tokyo); 2014; 62(5):491-3. PubMed ID: 24789933
[TBL] [Abstract][Full Text] [Related]
18. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
20. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
